Novacea Inc (NOVC)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Evan Loh
Employees:
210
75 PARK PLAZA, 4TH FLOOR, BOSTON, MA 02116
(617) 807-6600

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Paratek Pharmaceuticals, Inc. focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens. SEYSARA, a tetracycline designed for the. treatment of moderate to severe acne vulgaris.

Data derived from most recent annual or quarterly report
Market Cap 8.451 Million Shares Outstanding9.39 Million Avg 30-day Volume 59.268 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.19
Price to Revenue1.2169 Debt to Equity-1.5557 EBITDA-70.059 Million
Price to Book Value0.0 Operating Margin-60.642700000000005 Enterprise Value343.126 Million
Current Ratio3.113 EPS Growth-0.564 Quick Ratio2.303
1 Yr BETA 0.3546 52-week High/Low 0.0 / Profit Margin-76.1001
Operating Cash Flow Growth-25.8454 Altman Z-Score-8.0643 Free Cash Flow to Firm -47.501 Million

Are you looking for this stock instead?

View SEC Filings from NOVC instead.

View recent insider trading info

Novacea Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NOVC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NOVC

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIGHAM MICHAEL EXEC. CHAIRMAN OF THE BOARD

  • Officer
  • Director
 1,237,827 2022-10-25 2

HASKEL WILLIAM M. CLO, GENERAL COUNSEL & SEC.

  • Officer
 442,183 2022-10-25 2

LOH EVAN CEO

  • Officer
  • Director
 1,287,742 2022-10-25 2

WOODROW ADAM PRESIDENT & CHIEF COMMERCIAL

  • Officer
 650,170 2022-10-25 2

BRENNER RANDALL B. CHIEF DEVELOPMENT & REGULATORY

  • Officer
 357,649 2022-10-25 2

FRANSON TIMOTHY R

  • Director
 30,000 2020-02-19 0

STEIN JEFFREY

  • Director
 26,625 2020-02-19 0

PETERSON KRISTINE

  • Director
 30,000 2020-02-19 0

DIETZ THOMAS JOHN

  • Director
 21,000 2020-02-19 0

RADIE ROBERT S

  • Director
 23,250 2020-02-19 0

HOFFMANN ROLF K

  • Director
 35,000 2020-02-19 0

PAGAN DOUGLAS W. CHIEF FINANCIAL OFFICER

  • Officer
 No longer subject to file 2019-04-05 0

BIGHAM MICHAEL CHAIRMAN AND CEO

BIGHAM MICHAEL CHAIRMAN AND CEO

  • Officer
  • Director
 257,167 2018-10-02 2

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

  • 10% Owner
 No longer subject to file 2015-05-28 0

KILEY THOMAS

  • Director
 No longer subject to file 2014-10-30 0

OCLASSEN GLENN A PRESIDENT AND CEO

  • Officer
  • Director
 No longer subject to file 2014-10-30 0

RAAB G KIRK

  • Director
 No longer subject to file 2014-10-30 0

PATTERSON LEONE D VICE PRESIDENT, CFO

  • Officer
 No longer subject to file 2014-10-30 0

LOAR MATTHEW M

  • Director
 No longer subject to file 2014-10-30 0

OMEGA FUND III, L.P.

OMEGA FUND III GP, L.P.

OMEGA FUND III G.P., LTD.

OMEGA FUND IV, L.P.

OMEGA FUND IV GP, L.P.

OMEGA FUND IV G.P. MANAGER, LTD.

OMEGA FUND MANAGEMENT LTD

SIGMA HOLDING LTD

STAMPACCHIA OTELLO

  • 10% Owner
 10,933,503 2014-10-30 0

KOLLINS JOHN A SVP, CHIEF BUSINESS OFFICER

  • Officer
 No longer subject to file 2014-10-30 0

RUEGSEGGER FREDERICK J

  • Director
 No longer subject to file 2014-10-30 0

NUNN JASON RALEIGH

  • Director
 No longer subject to file 2014-10-30 0

SINGH NIKHILESH N SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
 No longer subject to file 2014-10-30 0

BOXMEYER KATHRYN M. SEE REMARKS

  • Officer
 0 2014-10-30 0

K/S DANISH BIOVENTURE

DANISH BIOVENTURE GENERAL PARTNER APS

  • 10% Owner
 1,266,486 2014-10-30 0

LIM RICHARD J.

  • Director
 0 2014-10-30 0

ROUMELL ASSET MANAGEMENT, LLC

  • 10% Owner
 2,207,511 2013-12-13 0

SOLOWAY THOMAS P EVP, CHIEF OPERATING OFFICER

  • Officer
 0 2013-07-15 0

EHRLICH CHRISTOPHER B

  • Director
 0 2013-04-10 0

WORTZMAN MARILYN E VP, FINANCE

  • Officer
 217 2012-04-16 0

LAPORTE KATHLEEN

  • Director
 0 2012-01-24 0

KENNEDY JOSEPH T VP AND GENERAL COUNSEL

  • Officer
 0 2011-12-01 0

INTERWEST PARTNERS IX, LP

ORONSKY ARNOLD L

GIANOS PHILIP T

KLIMAN GILBERT H

CASH HARVEY B

ROSCH THOMAS L

HOLMES W STEPHEN

NASR KHALED

CLEVELAND BRUCE A

PEPPER DOUGLAS A

  • 10% Owner
 1,983,884 2011-09-21 0

INTERWEST MANAGEMENT PARTNERS IX, LLC

KJELLSON NINA S

  • 10% Owner
 1,983,884 2011-09-21 0

NEW LEAF VENTURES I, L.P.

NEW LEAF VENTURE MANAGEMENT I, L.P.

NEW LEAF VENTURE MANAGEMENT I, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

LATHI VIJAY K

DELAGARDELLE JEANI

HUNT RONALD

AKKARAJU SRINIVAS

  • FORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNER
 No longer subject to file 2011-07-18 0

TURNER DANIEL K III

  • Director
 1,099,288 2011-03-29 0

WALKER JOHN PETER

  • Director
 0 2011-02-02 0

SAMUELS CAMILLE D

  • Director
 0 2011-02-02 0

MOORE TERRENCE O VP, MARKETING AND SALES

  • Officer
 3,928 2011-02-02 0

KOPPY SUSAN VP, CORPORATE DEVELOPMENT

  • Officer
 0 2009-02-12 0

NEWHALL CHARLES W III

  • 10% Owner
 2,083,426 2009-01-30 0

KRAMLICH C RICHARD

  • 10% Owner
 2,083,426 2009-01-30 0

BARRIS PETER J

  • 10% Owner
 2,083,426 2009-01-30 0

PERRY MARK W

  • 10% Owner
 2,083,426 2009-01-30 0

NEW ENTERPRISE ASSOCIATES 10 L P

  • 10% Owner
 No longer subject to file 2009-01-30 0

TRAINOR III EUGENE A

  • 10% Owner
 2,083,426 2009-01-30 0

BARRETT M JAMES

  • 10% Owner
 2,083,426 2009-01-30 0

NEA PARTNERS 10 L P

  • 10% Owner
 No longer subject to file 2009-01-30 0

SANDELL SCOTT D

  • 10% Owner
 2,083,426 2009-01-30 0

RAAB MICHAEL

  • Director
 No longer subject to file 2009-01-30 0

TREU JESSE I

  • 10% Owner
 9,289,794 2009-01-28 0

BLAIR JAMES C

  • 10% Owner
 9,289,794 2009-01-28 0

DP V ASSOCIATES LP

  • 10% Owner
 67,875 2009-01-28 0

DOMAIN PARTNERS V LP

  • 10% Owner
 2,907,523 2009-01-28 0

DOVEY BRIAN H

  • 10% Owner
 9,289,794 2009-01-28 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
 9,289,794 2009-01-28 0

ALBINI EDWARD C V.P., CHIEF FINANCIAL OFFICER

  • Officer
 18,897 2008-05-09 0

SINGH AMAR P CHF. COMMERCIALIZATION OFFICER

  • Officer
 8,741 2008-05-09 0

SEARS LOWELL

  • Director
 35,714 2008-02-13 0

HEMBERGER JUDITH A

  • Director
 0 2008-02-13 0

BRADBURY DANIEL

  • Director
 35,714 2008-02-13 0

HEALY JAMES

  • Director
  • 10% Owner
 0 2008-02-13 0

WEBER ECKARD

  • Director
 342,857 2008-02-13 0

SCHNIPPER EDWARD F. EXECUTIVE VP, CMO

  • Officer
 0 2007-12-12 0

ANG IVY V.P., HUMAN RESOURCES

  • Officer
 51,623 2007-10-11 0

MORE ROBERT J

  • 10% Owner
 73,575 2007-06-06 0

CURD JOHN G PRESIDENT, CMO

  • Officer
 45,642 2007-05-30 0

HEALY JAMES

POWELL MICHAEL

AZAN ALAIN

SOFINNOVA MANAGEMENT V LLC

SOFINNOVA VENTURE AFFILIATES V LP

SOFINNOVA VENTURE PARTNERS V LP

SOFINNOVA VENTURE PRINCIPALS V LP

  • Director
  • 10% Owner
 2,261,749 2006-05-15 0

SAMUELS CAMILLE D

VERSANT VENTURE CAPITAL II, LP

VERSANT SIDE FUND II, LP

VERSANT AFFILIATES FUND II-A, LP

VERSANT VENTURES II LLC

MILDER DONALD B

LUBASH BARBARA N

ATWOOD BRIAN G

JAFFE ROSS A MD

COLELLA SAMUEL D

  • Director
  • 10% Owner
 2,074,668 2006-05-15 0

ROBERTSON REBECCA B

LINK WILLIAM J PHD

WARDEN CHARLES M

BOLZON BRADLEY J PHD

  • 10% Owner
 2,074,668 2006-05-15 0

GOODWIN BRADFORD S CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 367,179 2006-05-15 0

DOMAIN ASSOCIATES

  • 10% Owner
 100,355 2006-05-09 0

MORRIS PETER

  • 10% Owner
 0 2006-05-09 0

VITULLO NICOLE

  • 10% Owner
 100,355 2006-05-09 0

HALAK BRIAN K

  • 10% Owner
 100,355 2006-05-09 0

CLOW FONG WANG SENIOR V.P., DEVELOPMENT

  • Officer
 192,855 2006-05-09 0

MOORIN JAY

  • Director
 0 2006-05-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BIGHAM MICHAEL - Director - Officer EXEC. CHAIRMAN OF THE BOARD

2022-10-27 19:00:42 -0400 2022-10-25 A 30,000 a 1,237,827 direct

BRENNER RANDALL B. - Officer CHIEF DEVELOPMENT & REGULATORY

2022-10-27 19:03:00 -0400 2022-10-25 A 8,500 a 357,649 direct

HASKEL WILLIAM M. - Officer CLO, GENERAL COUNSEL & SEC.

2022-10-27 19:04:57 -0400 2022-10-25 A 9,250 a 442,183 direct

LOH EVAN - Director - Officer CEO

2022-10-27 19:06:47 -0400 2022-10-25 A 30,000 a 1,287,742 direct

WOODROW ADAM - Officer PRESIDENT & CHIEF COMMERCIAL

2022-10-27 19:08:36 -0400 2022-10-25 A 15,000 a 650,170 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments